The percentage of TREM-2+CD4+ T cells was significantly increased in patients with nonsevere (35.56 ± 2.74%) or severe (75.18 ± 3.96%) COVID-19, compared to the low level in healthy donors (6.16 ± 0.49%) (Fig. 1D). This evidence concerns the gene CD4 and COVID-19.